Have a personal or library account? Click to login
A New Case of Schnitzler Syndrome in Bulgaria Cover

A New Case of Schnitzler Syndrome in Bulgaria

Open Access
|Dec 2018

References

  1. 1. Lipsker D. The Schnitzler syndrome. Orphanet Journal of Rare Diseases, 2010, 5 (38), 1-8.10.1186/1750-1172-5-38301845421143856
  2. 2. De Koning H. Schnitzler’s syndrome: lessons from 281 cases. Clinical and Translational Allergy, 2014, 4(41), 1-15.10.1186/2045-7022-4-41440582725905009
  3. 3. Simon A, Asli B, Braun-Falco M, et al. Schnitzler’s syndrome: diagnosis, treatment, and follow-up. Allergy, 2013, 68, 562-568.10.1111/all.1212923480774
  4. 4. Soubrier M. Schnitzler syndrome. Joint Bone Spine, 2008, 75, 263-266.10.1016/j.jbspin.2007.07.01418378180
  5. 5. Sokumbi O, Drage L, Peters M, et al. Clinical and histopatho-logic review of Schnitzler syndrome: The Mayo Clinic experience (1972-2011). J Am Acad Dermatol., 2012, 67(6), 1289-95.10.1016/j.jaad.2012.04.02722627038
  6. 6. de Koning H, Bodar E, Meer J, et al. Schnitzler syndrome: Beyond the case reports: Review and follow-up of 94 patients with an emphasis on prognosis and treatment. Seminars in Arthritis and Rheumatism., 2007, 37, 137-148.10.1016/j.semarthrit.2007.04.00117586002
  7. 7. Terpos E, Asli B, Christoulas D. et al. Increased angiogenesis and enhanced bone formation in patients with IghM monoclonal gammopathy and urticarial skin rash: new insight into the biology of Schnitzler syndrome. Haematologica, 2012, 97(11), 1699-1703.10.3324/haematol.2012.067306348744322689688
  8. 8. Lim W, Shumak K, Reis M, et al. Malignant evolution of Schnitzler’s Syndrome: chronic urticarial and IgM monoclonal gammopathy: report of a new case and review of the literature. Leuk Lymphoma, 2002, 43,181-8.10.1080/1042819021018111908725
  9. 9. Koch A, Tchernev G, Chokoeva A. Schnitzler syndrome responding to Interleukin-1 antagonist Anakinra. Journal of biological regulators &homeostatic agents, 2015, 29, 2 (S).
  10. 10. Kamusheva M, Donev S, Kirilova-Doneva M, et al. Direct medical costs for treatment of Schnitzler syndrome – a case study. Rare disease, 2017, 8(1), 3-6.
  11. 11. Lipsker D, Spehner D, Drillien R, et al. Schitzler syndrome: heterogeneous immunopathological findings involving IgM skin interactions. Br J Drematol., 2000, 142,954-959.10.1046/j.1365-2133.2000.03477.x10809854
  12. 12. Lipsker D, Veran Y, Grunenberger F et al. The Schitzler syndrome. Four new cases and review of the literature. Medicine, 2001, 80, 37-44.10.1097/00005792-200101000-0000411204501
  13. 13. Krause K, Weller K, Stefaniak R, et al. Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study. Allergy, 2012, 67(7), 943-950.10.1111/j.1398-9995.2012.02843.x
  14. 14. Jarrett P. Schnitzler syndrome. 2009; Available from: http://www.dermnetnz.org/topics/schnitzler-syndrome
  15. 15. Bozeman S, Lewis S. Schnitzler syndrome successfully treated with methotrexate. Ann Allergy Asthma Immunol., 2008, 101(2), 219-225.10.1016/S1081-1206(10)60213-X
  16. 16. Peterlana D, Puccetti A, Tinazzi E, et al. Schnitzler’s syndrome treated successfully with intravenous pulse cyclophosphamide-to suppress the immune system. Scand J Rheumatol., 2005, 34(4), 328-30.10.1080/0300974051001773316195169
DOI: https://doi.org/10.2478/amb-2018-0021 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Language: English
Page range: 58 - 62
Published on: Dec 19, 2018
Published by: Sofia Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 M. Kirilova-Doneva, M. Kamusheva, S. Donev, I. Popova, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.